PFBT
KURA icon

Parkside Financial Bank & Trust’s Kura Oncology KURA Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$570 Hold
70
– – ﹤0.01% 2543
2025
Q4 		$728 Hold
70
– – ﹤0.01% 2451
2025
Q3 		$621 Buy
+70
New +$499 ﹤0.01% 2461

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's KURA Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Kura Oncology (KURA) position steady in Q1 2026 at 70 shares worth $570. The position accounts for ﹤0.01% of the portfolio, ranked #2543.

Parkside Financial Bank & Trust first reported a position in KURA in Q3 2025 and has held it in 3 quarters since. The position peaked at $728 in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • Parkside Financial Bank & Trust held 70 shares of Kura Oncology worth $570 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Kura Oncology share count unchanged in Q1 2026.
  • Kura Oncology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2543 holding.
  • Parkside Financial Bank & Trust first reported a position in Kura Oncology in Q3 2025 and has held it in 3 quarters since.
  • Parkside Financial Bank & Trust's Kura Oncology position peaked at $728 in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.